Bladder Perivascular Epithelioid Cell Neoplasm With Transcription Factor E3 Gene Rearrangement Treated by mTOR Inhibitor and Partial Cystectomy: A Case Report
Kimika Kaeriyama,
Tadashi Kakitsuba,
Wonseok Seo,
Tetsuyuki Kurokawa,
Akifumi Muramoto,
Yuzuru Ariga,
Koji Suzuki,
Yoshiaki Imamura,
Hideaki Okajima,
Naoki Terada IJU Case Reports
· Wiley
· 2026-11-05
· DOI: 10.1002/iju5.70297
Аннотация
IJU Case Reports, Volume 9, Issue 6, November 2026.
Kimika Kaeriyama, Tadashi Kakitsuba, Wonseok Seo, Tetsuyuki Kurokawa, Akifumi Muramoto, Yuzuru Ariga et al. Bladder Perivascular Epithelioid Cell Neoplasm With Transcription Factor E3 Gene Rearrangement Treated by mTOR Inhibitor and Partial Cystectomy: A Case Report. // IJU Case Reports. – 2026. – DOI: 10.1002/iju5.70297. – URL: https://onlinelibrary.wiley.com/doi/10.1002/iju5.70297?af=R
Kimika Kaeriyama, Tadashi Kakitsuba, Wonseok Seo, Tetsuyuki Kurokawa, Akifumi Muramoto, Yuzuru Ariga, Koji Suzuki, Yoshiaki Imamura, Hideaki Okajima, & Naoki Terada (2026). Bladder Perivascular Epithelioid Cell Neoplasm With Transcription Factor E3 Gene Rearrangement Treated by mTOR Inhibitor and Partial Cystectomy: A Case Report. IJU Case Reports. https://doi.org/10.1002/iju5.70297
Kimika Kaeriyama, et al. “Bladder Perivascular Epithelioid Cell Neoplasm With Transcription Factor E3 Gene Rearrangement Treated by mTOR Inhibitor and Partial Cystectomy: A Case Report.” IJU Case Reports, 2026. doi:10.1002/iju5.70297.
@article{Kaeriyama2026,
title = {Bladder Perivascular Epithelioid Cell Neoplasm With Transcription Factor E3 Gene Rearrangement Treated by mTOR Inhibitor and Partial Cystectomy: A Case Report},
author = {Kaeriyama, Kimika and Kakitsuba, Tadashi and Seo, Wonseok and Kurokawa, Tetsuyuki and Muramoto, Akifumi and Ariga, Yuzuru and Suzuki, Koji and Imamura, Yoshiaki and Okajima, Hideaki and Terada, Naoki},
journal = {IJU Case Reports},
year = {2026},
doi = {10.1002/iju5.70297},
url = {https://onlinelibrary.wiley.com/doi/10.1002/iju5.70297?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...